3Letrent SP, Pollack GM, Brouwer KR, et al. Effects of a potent and specific P-glycoprotein inhibitor on the blood-brain barrier distribution and antinociceptive effect of morphine in the rat[J]. Drug Metab Dispos,1999,27(7) :827.
4Seegers U,Potschka H,Looscher W. Transient increase of P-glyeoprotein expression in endothelium and parenchyma of limbic brain regions in the kainate model of temporal lobe epilepsy[J]. Eilepsy Resarch, 2002, 51(3) :257.
5Reinhardt CA, Gloor SM. Co-culture blood-brain barrier models and their use for pharmatoxicologial screening[J] .Toxicol in Vitro, 1997,11(5):513.
6Zhang Y, Bachmeier C, Miller DW, In vitro and in vivo models for assessing drug efflux transporter activity[J]. Adv Drug Delivery Rev,2003,55(1) :31.
7Fromm MF. The influence of MDR 1 polmyorphisms on P-glycprotein expression and function in humans[J]. Adv Drug Deliv Rev,2002,54(10): 1295.
8Lin JH. Drug-drug interaction mediated by inhibition and induction of Pglycoprotein[ J]. Adv Drug Deliv Rev,2003,55(1):53.
9Varma MV, Ashodraj Y, Dey CS. P-glycoprotein inhibitors and their screening:a perspective from bioavailability enhancement[J]. Pharmacological Research,2003,48(4) :347.
10Dantzing AH, Alwis DPD, Burgess M. Consideration in the design and development of transport[J] ,Adv Drug Deliv Rev,2003,55(1):133.
4Basak SC,Gute BD,Drewes LR.Prediction blood-brain transport of drugs:A computation approach[J].Pharm Res,1996,13(5):775-778.
5Yoshikawa T,Sakaeda T,Sugawara T,et al.A novel chemical delivery system for brain targeting[J].Adv Drug Delivery Rev,1999,36(2-3):255-275.
6Tsuji A,Tamai I.Carrier-mediated or specialized transport of drugs across the blood-brain barrier[J].Adv Drug Delivery Rev,1999,36(2-3):277-290.
7Chow H-HS,Chen Z,Matsuura GT.Direct transport of cocaine from the nasal cavity to the brain following intranasal cocaine administration in rats[J].J Pharm Sci,1999,88(8):754-758.
8Schinkel AH.P-Glycoprotein,a gatekeeper in the blood-brain barrier[J].Adv Drug Del Rev,1999,36(2-3):179-194.
9Matsuzaki J,Yamamoto C,Miyama T,et al.Contribution of P-glycoprotein to bunitrol efflux across blood-brain barrer[J].Biopharm Drug Dispos,1999,20(2):85-90.
10Kawahara M,Sakata A,Miyashita T,et al.Physiologically based pharmacokinetics of digoxin mdrla knockout mice[J].J Pharm Sci,1999,88(12):1281-1287.
4Loscher W,Potschka H.Blood-brain barrier active efflux transporters:ATP-binding cassette gene family.NeuroRx,2005,2:86-98.
5Lee JY,Urbatsch IL,Senior AE,et al.Projection structure of P-glycoprotein by electron microscopy.Evidence for a closed conformation of the nucleotide binding domains.J Biol Chem,2002,277:40125-40131.
6Borst P,Evers R,Kool M,et al.A family of drug transporters:the multidrug resistance-associated proteins.J Natl Cancer Inst,2000,92:1295-1302.
7Lee YJ,Kusuhara H,Jonker JW,et al.Investigation of efflux transport of dehydroepiandrosterone sulfate and mitoxantrone at the mouse blood-brain barrier:a minor role of breast cancer resistance protein.J Pharmacol Exp Ther,2005,312:44-52.
8Bielder JL,Reiehm H.Cellular resistance to actinomycin D in Chinese hamster cells in vitro:cross-resistance,radioautographic,and cytogenetic studies.Cancer Res,1970,30:1174-1184.
9Juliano RL,Ling V.A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants.Biochim Biophys Acta,1976,455:152-162.
10Cordon-Cardo C,O'Brien JP,Casals D,et al.Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites.Proc Natl Acad Sci USA,1989,86:695-698.
